Who is sponsoring NCT04726436?

NCT04726436 is sponsored by Assiut University.

What drugs are being tested in NCT04726436?

Interventions in NCT04726436: Dextrose 5% in water, Dextrose 10%, Saline placebo.

What condition does NCT04726436 study?

NCT04726436 studies Postoperative Nausea and Vomiting.

Is NCT04726436 still recruiting?

NCT04726436 is currently completed. Last updated 30 August 2021.

Last reviewed 2021-08-30 · How we verify

NCT04726436

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dextrose Effect on Postoperative Nausea and Vomiting (PONV)

Completed NA Last updated 30 August 2021

What this trial tests

NA trial testing Dextrose 5% in water in Postoperative Nausea and Vomiting in 120 participants. Completed in 1 May 2021.

Timeline

25 January 2021

Primary endpoint
1 April 2021

1 May 2021

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	120
Start date	25 January 2021
Primary completion	1 April 2021
Estimated completion	1 May 2021
Sites	1 location across Egypt

Drugs / interventions tested

Dextrose 5% in water — full drug profile →
Dextrose 10% — full drug profile →
Saline placebo

Conditions studied

Postoperative Nausea and Vomiting — all drugs for Postoperative Nausea and Vomiting →

Sponsor

Assiut University

Who can join

Adults 18 to 65, female only, with Postoperative Nausea and Vomiting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study to assess which time and dose of dextrose solution more effective in decreasing postoperative nausea and vomiting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dextrose 5% in water

Trials testing the same drug.

NCT06547554 — A DDI Study to Investigate PK and Safety of Cefiderocol in Combination With Xeruborbactam in Healthy Adult Participants · Phase 1 · completed
NCT06427694 — Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study · recruiting
NCT06308887 — Comparison of Ultrasound-Guided Perimeniscal Steroid and 5% Dextrose Injections in Knee Osteoarthritis · Phase 4 · completed
NCT05840471 — Tranexamic Acid as an Intervention in Abruptio Placenta · NA · completed
NCT05429827 — The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04726436 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04726436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing